Erratum: Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells (Pharmacological Research (2015) 102 (176-183) DOI: 10.1016/j.phrs.2015.10.002);Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells

Pharmacological Research

Volumn 102, Issue , 2015, Pages 176-183

  Choi, Joon Seok ^a   Kim, Jun Ki ^b   Yang, Yoon Jung ^c   Kim, Yeseul ^d   Kim, Pilhan ^d   Park, Sang Gyu ^e   Cho, Eun Young ^f   Lee, Dae Ho ^f   Choi, Jin Woo ^c,g  

^a Catholic University of Daegu   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Wonkwang University   (South Korea)

^d Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^e Ajou University   (South Korea)

^f Wonkwang University School of Medicine   (South Korea)

^g Seoul National University   (South Korea)

Author keywords

Cirrhosis; Cromolyn; Hepatic stellate cell; Hepatocyte; Liver fibrosis; Pharmacogenomics

Indexed keywords

ANTIFIBROTIC AGENT; BETA GALACTOSIDASE; COLLAGEN; CROMOGLYCATE DISODIUM; CYCLINE; SMOOTH MUSCLE ACTIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; STELLATE CELL; CELL AGING; CELL CULTURE; DRUG EFFECTS; LIVER; METABOLISM;

APOPTOSIS; CELL AGING; CELLS, CULTURED; COLLAGEN; CROMOLYN SODIUM; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; LIVER; LIVER CIRRHOSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84945190505     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.04.017     Document Type: Erratum

References (36)

1. C. Mogler, M. Wieland, C. Konig, J. Hu, A. Runge, C. Korn, E. Besemfelder, K. Breitkopf-Heinlein, D. Komljenovic, S. Dooley, P. Schirmacher, T. Longerich, and H.G. Augustin Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage EMBO Mol. Med. 7 2015 332 338
2. G. Huang, and D.R. Brigstock Regulation of hepatic stellate cells by connective tissue growth factor Front. Biosci. 17 2012 2495 2507
3. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J. Clin. Invest. 117 2007 539 548
4. S.L. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver Physiol. Rev. 88 2008 125 172
5. M. Neef, M. Ledermann, H. Saegesser, V. Schneider, N. Widmer, L.A. Decosterd, B. Rochat, and J. Reichen Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term J. Hepatol. 44 2006 167 175
6. E. Patsenker, and F. Stickel Role of integrins in fibrosing liver diseases Am. J. Physiol. Gastrointest. Liver Physiol. 301 2011 G425 G434
7. Q.Y. Yao, B.L. Xu, J.Y. Wang, H.C. Liu, S.C. Zhang, and C.T. Tu Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats BMC Complem. Altern. Med. 12 2012 156
8. J.I. Tzeng, M.F. Chen, H.H. Chung, and J.T. Cheng Silymarin decreases connective tissue growth factor to improve liver fibrosis in rats treated with carbon tetrachloride Phytother. Res.: PTR 27 2013 1023 1028
9. C. Zhang, Y. Zhu, J. Wan, H. Xu, H. Shi, and X. Lu Effects of Ginkgo biloba extract on cell proliferation, cytokines and extracellular matrix of hepatic stellate cells Liver Int. 26 2006 1283 1290
10. Y.C. Hsu, Y.L. Lin, Y.T. Chiu, M.S. Shiao, C.Y. Lee, and Y.T. Huang Antifibrotic effects of salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats J. Biomed. Sci. 12 2005 185 195
11. O.A. Gressner, and A.M. Gressner Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases Liver Int. 28 2008 1065 1079
12. A. Mauviel Transforming growth factor-beta signaling in skin: stromal to epithelial cross-talk J. Invest. Dermatol. 129 2009 7 9
13. S.L. Wen, J.H. Gao, W.J. Yang, Y.Y. Lu, H. Tong, Z.Y. Huang, Z.X. Liu, and C.W. Tang Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes J. Gastroenterol. Hepatol. 29 2014 1932 1942
14. K. Iwaisako, D.A. Brenner, and T. Kisseleva What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis J. Gastroenterol. Hepatol. 27 Suppl. 2 2012 65 68
15. S.U. Wiemann, A. Satyanarayana, M. Tsahuridu, H.L. Tillmann, L. Zender, J. Klempnauer, P. Flemming, S. Franco, M.A. Blasco, M.P. Manns, and K.L. Rudolph Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis FASEB J. 16 2002 935 942
16. M.P. Giampieri, A.M. Jezequel, and F. Orlandi The lipocytes in normal human liver. A quantitative study Digestion 22 1981 165 169
17. S.L. Friedman, D.C. Rockey, R.F. McGuire, J.J. Maher, J.K. Boyles, and G. Yamasaki Isolated hepatic lipocytes and kupffer cells from normal human liver: morphological and functional characteristics in primary culture Hepatology 15 1992 234 243
18. J.D. Blakey, and I.P. Hall Current progress in pharmacogenetics Br. J. Clin. Pharmacol. 71 2011 824 831
19. J. Lamb, E.D. Crawford, D. Peck, J.W. Modell, I.C. Blat, M.J. Wrobel, J. Lerner, J.P. Brunet, A. Subramanian, K.N. Ross, M. Reich, H. Hieronymus, G. Wei, S.A. Armstrong, S.J. Haggarty, P.A. Clemons, R. Wei, S.A. Carr, E.S. Lander, and T.R. Golub The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935
20. G. Wei, D. Twomey, J. Lamb, K. Schlis, J. Agarwal, R.W. Stam, J.T. Opferman, S.E. Sallan, M.L. den Boer, R. Pieters, T.R. Golub, and S.A. Armstrong Gene expression-based chemical genomics identifies rapamycin as a modulator of mcl1 and glucocorticoid resistance Cancer Cell 10 2006 331 342
21. J.E. Huettner, and B.P. Bean Block of n-methyl-d-aspartate-activated current by the anticonvulsant mk-801: Selective binding to open channels Proc. Natl. Acad. Sci. U. S. A. 85 1988 1307 1311
22. J.K. Schmitt, and S.B. Johns Altering therapy of type ii diabetes mellitus from insulin to tolazamide increases blood pressure in spite of weight loss Am. J. Hypertens. 8 1995 520 523
23. K. Renko, C.S. Hoefig, F. Hiller, L. Schomburg, and J. Kohrle Identification of iopanoic acid as substrate of type 1 deiodinase by a novel nonradioactive iodide-release assay Endocrinology 153 2012 2506 2513
24. D.M. Bissell, S.S. Wang, W.R. Jarnagin, and F.J. Roll Cell-specific expression of transforming growth factor-beta in rat liver:Evidence for autocrine regulation of hepatocyte proliferation J. Clin. Invest. 96 1995 447 455
25. D. Schuppan, and Y.O. Kim Evolving therapies for liver fibrosis J. Clin. Invest. 123 2013 1887 1901
26. P. Kanellakis, M. Ditiatkovski, G. Kostolias, and A. Bobik A pro-fibrotic role for interleukin-4 in cardiac pressure overload Cardiovasc. Res. 95 2012 77 85
27. A. Veerappan, N.J. O'Connor, J. Brazin, A.C. Reid, A. Jung, D. McGee, B. Summers, D. Branch-Elliman, B. Stiles, S. Worgall, R.J. Kaner, and R.B. Silver Mast cells: a pivotal role in pulmonary fibrosis DNA Cell Biol. 32 2013 206 218
28. B.M. Henz Exploring the mast cell enigma: a personal reflection of what remains to be done Exp. Dermatol. 17 2008 91 99
29. L. Amiot, N. Vu, M. Rauch, A. L'Helgoualc'h, F. Chalmel, H. Gascan, B. Turlin, D. Guyader, and M. Samson Expression of hla-g by mast cells is associated with hepatitis c virus-induced liver fibrosis J. Hepatol. 60 2014 245 252
30. M. Ishii, M. Iwai, Y. Harada, T. Morikawa, T. Okanoue, T. Kishikawa, Y. Tsuchihashi, K. Hanai, and N. Arizono A role of mast cells for hepatic fibrosis in primary sclerosing cholangitis Hepatol. Res. 31 2005 127 131
31. D.H. Jeong, G.P. Lee, W.I. Jeong, S.H. Do, H.J. Yang, D.W. Yuan, H.Y. Park, K.J. Kim, and K.S. Jeong Alterations of mast cells and tgf-beta1 on the silymarin treatment for ccl(4)-induced hepatic fibrosis World J. Gastroenterol.: WJG 11 2005 1141 1148
32. Y.L. Jin, Q. Zhou, C. Tian, H.G. Liu, Y. Hayashi, and H. Enzan Effects of mast cells on degradation of collagen fibers in dimethylnitrosamine-induced hepatic fibrosis of rat Zhonghua Bing Li Xue Za Zhi Chin. J. Pathol. 41 2012 260 264
33. L. Amiot, N. Vu, and M. Samson Biology of the immunomodulatory molecule hla-g in human liver diseases J. Hepatol. 2015
34. H. Amayasu, M. Nakabayashi, K. Akahori, Y. Ishizaki, T. Shoji, H. Nakagawa, H. Hasegawa, and S. Yoshida Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma Ann. Allergy Immunol. 87 2001 146 150
35. F. Fend, and M. Raffeld Laser capture microdissection in pathology J. Clin. Pathol. 53 2000 666 672
36. T. Kim, C.S. Lim, and B.K. Kaang Cell type-specific gene expression profiling in brain tissue: Comparison among trap, lcm and rna-seq BMB Rep. 48 July 7 2015 388 394